Clinical Trials for Mesothelioma Patients: Pemetrexed Disodium and Cisplatin Study Information

Read more information about the current clinical trial study being conducted to study the effects of pemetrexed disodium and cisplatin for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, the study is currently being conducted only in Zurich, Switzerland.

Recruitment Information:

Recruitment Status: Recruiting

Enrollment: 155

Start Date: November 2005

Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)

Primary Objectives:

• Evaluate the short-term outcomes and feasibility of neoadjuvant therapy with pemetrexed disodium and cisplatin followed by extrapleural pneumonectomy in patients with malignant pleural mesothelioma.

• Evaluate the long-term outcomes and feasibility of postoperative hemithoracic radiotherapy in patients with R0 or R1 resection.

Secondary Objectives:

• Determine the quality of life of these patients.

• Identify predictive and prognostic markers in these patients.

• Determine relapse-free or progression-free survival and overall survival of these patients.

• Collect tissue and blood from these patients.

Courtesy of ClinicalTrials.gov.

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney